COPENHAGEN, Denmark — The Omicron variant has moved the COVID-19 pandemic into a new phase and could bring it to an end in Europe, the WHO Europe director said Sunday.
“It’s plausible that the region is moving towards a kind of pandemic endgame,” Hans Kluge told AFP in an interview, adding that Omicron could infect 60 percent of Europeans by March.
Once the current surge of Omicron currently sweeping across Europe subsides, “there will be for quite some weeks and months a global immunity, either thanks to the vaccine or because people have immunity due to the infection, and also lowering seasonality.”
“So we anticipate that there will be a period of quiet before COVID-19 may come back towards the end of the year, but not necessarily the pandemic coming back,” Kluge said.
The Omicron variant, which studies have shown generally leads to less severe infection than the Delta variant did, at least among vaccinated people, has raised long-awaited hopes that COVID-19 is starting to shift from a pandemic to a more manageable endemic illness like seasonal flu.
Get The Times of Israel's Daily Edition
by email and never miss our top stories
By signing up, you agree to the
terms
World Health Organization Director for Europe Hans Kluge arrives for a press conference in Rome, Italy, February 26, 2020. (Gregorio Borgia/AP)
“There is a lot of talk about endemic, but endemic means… that it is possible to predict what’s going to happen. This virus has surprised (us) more than once so we have to be very careful,” Kluge said.
In the WHO Europe region, which is made up of 53 countries, including several in Central Asia, Omicron represented 15 percent of new cases as of January 18, compared to 6.3% a week earlier, the health body said.
Telling an urgent story
During a global pandemic, one tiny country is producing research that's helping to guide health policy across the world. How effective are COVID-19 vaccines? After the initial two shots, does a third dose help? What about a fourth?
When The Times of Israel began covering COVID-19, we had no idea that our small beat would become such a central part of the global story. Who could have known that Israel would be first at nearly every juncture of the vaccination story - and generate the research that's so urgently needed today?
Our team has covered this story with the rigor and accuracy that characterizes Times of Israel reporting across topics. If it’s important to you that this kind of media organization exists and thrives, I urge you to support our work. Will you join The Times of Israel Community today?
Thank you,
Nathan Jeffay, Health & Science Correspondent
Join our Community
Join our Community
Already a member? Sign in to stop seeing this
You’re serious. We appreciate that!
We’re really pleased that you’ve read X Times of Israel articles in the past month.
That’s why we come to work every day - to provide discerning readers like you with must-read coverage of Israel and the Jewish world.
So now we have a request. Unlike other news outlets, we haven’t put up a paywall. But as the journalism we do is costly, we invite readers for whom The Times of Israel has become important to help support our work by joining The Times of Israel Community.
For as little as $6 a month you can help support our quality journalism while enjoying The Times of Israel AD-FREE, as well as accessing exclusive content available only to Times of Israel Community members.
Join Our Community
Join Our Community
Already a member? Sign in to stop seeing this
comments